- 米国企業
- Viridian Therapeutics, Inc.\DE
Viridian Therapeutics, Inc.\DEVRDN
時価総額
PER
| 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
| Collaboration revenue - related party | - | - | - | - | 8 | 4 | 1 | 3 | 2 | 0 |
| Research and Development Expense (Excluding Acquired in Process Cost) | - | - | - | - | - | - | 28 | 57 | 101 | 160 |
| General and administrative | 7 | 8 | 8 | 11 | 11 | 12 | 13 | 26 | 35 | 95 |
| Total operating expenses | 11 | 14 | 16 | 31 | 41 | 46 | 111 | 83 | 136 | 255 |
| Loss from operations | -7 | -11 | -13 | -27 | -33 | -42 | -110 | -80 | -134 | -254 |
| Interest and other income | - | - | - | - | - | - | - | - | 5 | 19 |
| Interest and other expense | - | - | - | 0 | 1 | 1 | 1 | 0 | 0 | 2 |
| Other income, net | - | - | - | 0 | 1 | 1 | 0 | 0 | 4 | 17 |
| Net loss | -8 | -11 | -13 | -27 | -33 | -42 | -111 | -79 | -130 | -238 |
| Earnings Per Share, Basic | - | - | - | - | - | - | - | -6.66 | -4.05 | -5.31 |
| Earnings Per Share, Diluted | - | - | - | - | - | - | - | -6.66 | -4.05 | -5.31 |
| Change in unrealized loss on investments | - | - | - | - | -0 | 0 | -0 | -0 | -0 | - |
| Net loss | -8 | -11 | -13 | -27 | -33 | -42 | -111 | -79 | -130 | -238 |
| Total other comprehensive (loss) gain | - | - | - | - | - | - | - | - | -0 | 1 |
| Change in unrealized (loss) gain on investments | - | - | - | - | - | - | - | - | - | 1 |
| Total other comprehensive (loss) gain | - | - | - | - | - | - | - | - | -0 | 1 |
| Total comprehensive loss | - | - | - | - | -33 | -42 | -111 | -80 | -130 | -237 |